For: | Viswanath A, Fouda S, Fernandez CJ, Pappachan JM. Metabolic-associated fatty liver disease and sarcopenia: A double whammy. World J Hepatol 2024; 16(2): 152-163 [PMID: 38495287 DOI: 10.4254/wjh.v16.i2.152] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v16/i2/152.htm |
Number | Citing Articles |
1 |
Gholam Reza Sivandzadeh, Ali Shahsavari, Elahe Meftah, Ramin Niknam, Ali Reza Safarpour. Effect of L-carnitine supplementation on muscle cramps in liver cirrhosis: results from a retrospective cohort study. BMC Gastroenterology 2025; 25(1) doi: 10.1186/s12876-025-03730-4
|
2 |
Marina Ribas Losasso, Maria Luiza Cesto Parussolo, Antony Oliveira Silva, Rosa Direito, Karina Quesada, Claudia Rucco Penteado Detregiachi, Marcelo Dib Bechara, Nahum Méndez-Sánchez, Ludovico Abenavoli, Adriano Cressoni Araújo, Ricardo de Alvares Goulart, Elen Landgraf Guiger, Lucas Fornari Laurindo, Sandra Maria Barbalho. Unraveling the Metabolic Pathways Between Metabolic-Associated Fatty Liver Disease (MAFLD) and Sarcopenia. International Journal of Molecular Sciences 2025; 26(10): 4673 doi: 10.3390/ijms26104673
|
3 |
Longshan Yang, Xiaojun Zeng. Lean-MAFLD: imperatives for updated evidence, mechanistic clarity, and methodological rigor. Hepatology International 2025; doi: 10.1007/s12072-025-10832-4
|
4 |
Yilin Wen, Ping Weng, Yueyue Li, Liming Yang, Chengju Li, Qingyang Chen, Yanni He, Wanping Zhang, Hui Hu, Zhiyi Yuan, Chao Yu. Triglyceride-Targeted Molecularly Imprinted Polymers Activate Lipophagy via Cargo Exchange for Nonalcoholic Fatty Liver Disease Treatment. ACS Applied Polymer Materials 2024; 6(12): 7265 doi: 10.1021/acsapm.4c01222
|
5 |
Rochelle Wong, Li-Yun Yuan. Sarcopenia and metabolic dysfunction associated steatotic liver disease: Time to address both. World Journal of Hepatology 2024; 16(6): 871-877 doi: 10.4254/wjh.v16.i6.871
|
6 |
Anuththara Upamali Abeykoon, Madhavi Priyanka Paranagama, Kavindra Kumara Wijesundera, Onela Canith Pathirana, Thilini Anupama Mahakapuge, Jayantha Rajapakse. In vitro antioxidant effects and in vivo hepatoprotective effects of Osbeckia octandra, Vernonia cinerea and Atalantia ceylanica on a high fat diet induced metabolic dysfunction-associated steatotic liver disease mouse model. BMC Complementary Medicine and Therapies 2025; 25(1) doi: 10.1186/s12906-025-04918-7
|